DocMorris Stock Based Compensation Over Time

DOCM Stock   5.85  0.17  2.99%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out DocMorris Performance and DocMorris Correlation.
  
Stock Based Compensation is likely to climb to about 4.9 M in 2026, whereas Stock Based Compensation To Revenue is likely to drop 0 in 2026.
It's important to distinguish between DocMorris' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DocMorris should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, DocMorris' market price signifies the transaction level at which participants voluntarily complete trades.

Cross Equities Stock Based Compensation Analysis

Compare DocMorris AG and related stocks such as IVF Hartmann Holding, Coltene Holding AG, and Newron Pharmaceuticals Stock Based Compensation Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AGraham Number
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
20102011201220132014201520162017201820192020202120222023202420252026
VBSN373 K373 K373 K373 K373 K373 K373 K373 K373 K373 K(14.4 M)(20.4 M)(13.3 M)1.4 M1.4 M1.6 M1.7 M
CLTN184 K184 K184 K184 K282 K304 K240 K284 K282 K310 K338 K330 K261 K187 K187 K215.1 K300.2 K
NWRN625 K842 K210 K833 K1.2 M2.3 M2.3 M1.7 M2.1 M2.1 M1.5 M762 K480 K197 K256 K294.4 K279.7 K
SANN2.6 M429 K429 K290 K759 KM4.7 M9.7 M7.4 M6.3 MM2.8 M5.5 MMM4.6 M4.8 M
MOLN831.8 K831.8 K831.8 K831.8 K2.3 M3.8 M2.9 M3.6 M3.7 M2.4 M2.9 M4.1 M5.1 M5.2 M4.1 M4.7 M3.7 M
ASCN1000 K900 K1.2 M1.6 M600 K500 K800 K300 K200 K600 K700 K(200 K)(900 K)300 K800 K720 K551.1 K
SHLTN244 K467 K385 K369 K322 K361 K490 K92 K634 K228 K82 K1.3 M1.8 M1.3 M366 K420.9 K571.2 K
ADXN526.8 K772.9 K580.5 K174.5 K275.7 K355.9 K197.3 K800.2 K2.3 M1.7 M1.2 M1.2 M3.7 M1.8 M1.8 M2.1 M1.2 M
EVE915.1 KM3.3 M2.2 MM3.8 M2.8 M3.3 M1.9 M1.2 M853.8 K1.1 M1.2 M4.4 M0.00.00.0

DocMorris AG and related stocks such as IVF Hartmann Holding, Coltene Holding AG, and Newron Pharmaceuticals Stock Based Compensation description

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

My Equities

My Current Equities and Potential Positions

DocMorris AG
DOCM
Specialization
Consumer Staples, Consumer Staples Distribution & Retail
Business AddressWalzmUehlestrasse 49, Frauenfeld,
ExchangeSIX Swiss Exchange
null 5.85

Additional Tools for DocMorris Stock Analysis

When running DocMorris' price analysis, check to measure DocMorris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocMorris is operating at the current time. Most of DocMorris' value examination focuses on studying past and present price action to predict the probability of DocMorris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocMorris' price. Additionally, you may evaluate how the addition of DocMorris to your portfolios can decrease your overall portfolio volatility.